1. Molecular imaging biomarkers for immune checkpoint inhibitor therapy

   van de Donk, P. P., Kist de Ruijter, L., Lub-de Hooge, M. N., Brouwers, A. H., van der Wekken, A. J., Oosting, S. F., Fehrmann, R. S., de Groot, D. J. A. & de Vries, E. G., 2020, In : Theranostics. 10, 4, p. 1708-1718 11 p.

   Research output: Contribution to journal › Review article › Academic › peer-review

2. Molecular imaging biomarkers for immune checkpoint inhibitor therapy

   van de Donk, P. P., Kist de Ruijter, L., Lub-de Hooge, M. N., Brouwers, A. H., van der Wekken, A. J., Oosting, S. F., Fehrmann, R. S. N., de Groot, D. J. A. & de Vries, E. G. E., 2020, In : Theranostics. 10, 4, p. 1708-1718 11 p.

   Research output: Contribution to journal › Review article › Academic › peer-review

3. Integrating molecular nuclear imaging in clinical research to improve anticancer therapy

   de Vries, E. G. E., Kist de Ruijter, L., Lub-de Hooge, M. N., Dierckx, R. A., Elias, S. G. & Oosting, S. F., Apr-2019, In : Nature Reviews Clinical Oncology. 16, 4, p. 241-255 15 p.

   Research output: Contribution to journal › Article › Academic › peer-review

View all (3) »